Jones Financial Companies
AGIO icon

Jones Financial Companies’s Agios Pharmaceuticals AGIO Stock Holding History

Jones Financial Companies’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
7,628
+3,584
+89% +$109K ﹤0.01% 2427
2026
Q1 		$119K Buy
4,044
+4,043
+404,300% +$115K ﹤0.01% 2605
2025
Q4 		$27 Hold
1
– – ﹤0.01% 4361
2025
Q3 		$39 Hold
1
– – ﹤0.01% 4187
2025
Q2 		$33 Buy
+1
New +$30 ﹤0.01% 3985

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Jones Financial Companies's AGIO Position: Q2 2026 in Review

Jones Financial Companies increased its Agios Pharmaceuticals (AGIO) stake by 89% in Q2 2026, buying an estimated $109K and bringing the position to 7,628 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

Jones Financial Companies first reported a position in AGIO in Q2 2025 and has held it in 5 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Jones Financial Companies held 7,628 shares of Agios Pharmaceuticals worth $289K as of Q2 2026.
  • Jones Financial Companies bought 3,584 Agios Pharmaceuticals shares in Q2 2026, an estimated $109K.
  • Agios Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2427 holding.
  • Jones Financial Companies first reported a position in Agios Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.